SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NPSP NPS Pharmaceutical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
363 40 0 NPSP
Emcee:  Jim Langdon Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
213Good luck!Miljenko Zuanic-3/29/2004
212>>SALT LAKE CITY, March 29 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, tuck-3/29/2004
211Today the put/call ratio in NPSP looks to be well over 1. Bearish sentiment bartuck-3/22/2004
210Sales projections from not too long ago are in this post: Message 19314593 whituck-3/12/2004
209Worth reading that FDA EMAC meeting document referenced in the previous post. Ptuck-3/12/2004
208>>Human parathyroid hormone and rat osteosarcoma 28 February 2002 Eric Gtuck-3/12/2004
207For easy comparison, here is the Lilly PR concerning the approval of Forteo: &gtuck-3/12/2004
206Have not heard. Let me look around. thnx (eom).mopgcw-3/11/2004
205>>Here's a quick look at the supposed advantages of the competing mAB Icebrg-3/11/2004
204Hearing Lehman analyst made negative comments about PREOS a couple of days ago. tuck-3/11/2004
203>>According to the Sensipar label, frequent monitoring of calcium levels ituck-3/10/2004
202SSB report: AMGN and NPSP's Cinacalcet Receives FDA Approval March 8, 2004 mopgcw-3/10/2004
201<i> Again, I hear, though I can't confirm, that Amgen got an approvablmopgcw-3/9/2004
200My take? Well, first I do not follow NPSP that closely. Second, I was following Miljenko Zuanic-3/9/2004
199From a GS report posted a few weeks ago by George, the predialysis market was $1tuck-3/9/2004
198No predialysis! fda.gov <<Cinacalcet is the first drug in the class of cMiljenko Zuanic-3/9/2004
197>>J Clin Endocrinol Metab. 2003 Dec;88(12):5644-9. The calcimimetic cintuck-3/9/2004
196Amgen's PR is more informative, but I still can't find information abouttuck-3/9/2004
195>>SALT LAKE CITY, March 8 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Ituck-3/9/2004
194From GS: Amgen Inc. EPS (FY Dec) 2004E $2.39, 2005E $2.84 Outperform/Neutral (AMmopgcw-3/8/2004
193fda.gov FDA Approves First in a New Class of Drugs to Treat Hyperparathyroidismscaram(o)uche-3/8/2004
192>>NEW YORK, Feb 25 (Reuters) - The chief executive of NPS Pharmaceuticals tuck-2/25/2004
191GS: NPSP (IL/N): Approval of Cinacalcet & Preos data expected Q1/04. Revisedmopgcw-2/11/2004
190<<Based upon these findings the company believes it has identified a non-cMiljenko Zuanic-2/10/2004
189The results for posterity: >>SALT LAKE CITY, Nov. 20 /PRNewswire-FirstCaltuck-2/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News